NUS establishes professorship in breast cancer genomics honouring patient

The National University of Singapore (NUS) has established a professorship in breast cancer genomics, marking a significant commitment to advancing research in oncology and precision medicine. The appointment underscores the university's dedication to understanding the genetic factors underlying breast cancer and improving treatment outcomes for patients across the region.

Surgical oncologist Mikael Hartman, a leading researcher in cancer genomics, has been named the inaugural holder of the professorship. Hartman's appointment reflects his substantial contributions to the field and his track record in translating genomic research into clinical applications that benefit cancer patients.

The professorship honours the memory of a patient whose involvement in and support for cancer research highlighted the importance of collaborative efforts between clinicians, researchers, and patients in advancing medical knowledge. Such dedicated funding positions recognizes the critical role patient advocacy plays in driving innovation within oncology.

The establishment of this position aligns with NUS's broader strategic focus on biomedical research and its commitment to positioning Singapore as a leading hub for cancer research and treatment in Southeast Asia. Through initiatives such as this professorship, the institution aims to strengthen its capacity in genomic medicine while fostering greater understanding of cancer biology at the molecular level.